Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomised Placebo-controlled Trial to Assess the Effect of a Single Administration of Ferric Carboxymaltose of 1000 mg Iron on Glucose Homeostasis, in Iron-deficient Non-anaemic Women of Childbearing Age.

NCT03191201 is registered in ClinicalTrials.gov with Prof Gérard WAEBER as lead sponsor.

NCT NCT03191201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03191201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomised Placebo-controlled Trial to Assess the Effect of a Single Administration of Ferric Carboxymaltose of 1000 mg Iron on Glucose Homeostasis, in Iron-deficient Non-anaemic Women of Childbearing Age.
Lead sponsor
Prof Gérard WAEBER
Phase
Phase 4
Overall status
Terminated
Start date
June 21, 2017
Completion date
March 9, 2020
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose metabolism disorders (including diabetes mellitus), iron toxicity, iron-deficiency, metabolic disorder, glucose, metabolic side effects of drugs, safety issues